Disclaimer
The discussion and conclusion are result from voluntary discussion within the discussion group and are not the authorized opinion of JBF or Japanese regulatory authority.
Financial & competing interests disclosure
M Niwa is an employee of Nippon Kayaku Co., Ltd. N Koseki is an employee of Kyorin Pharmaceutical Co., Ltd. Y Hashimoto is an employee of Ono Pharmaceutical Co., Ltd. N Nishimura is an employee of Sumika Chemical Analysis Service, Ltd. T Mayumi is an employee of Mitsubishi Tanabe Pharma Corporation. M Satsukawa is an employee of Kaken Pharmaceutical Co., Ltd. T Uchimura is an employee of Chugai Research Institute for Medical Science, Inc. Y Yasuda is an employee of Toray Research Center, Inc. H Yokoi is an employee of Otsuka Pharmaceutical Co., Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Acknowledgements
The authors thank steering committee of JBF for providing authors the chance to discuss the item of interest and to present the results of discussion. The authors also thank JBF partners for their participation to the survey and attendees of the 6th JBF symposium for discussing at the poster session of the symposium.